Myos Rens Technology: Climbs on positive results from university study

Medavail Holdings

19/06/2019 13:11

** Shares of nutritional products maker  MYOS.O  jump 15.4%
to $1.50 in premarket trading after co posts positive top-line
results for Fortetropin from a joint study by two universities
    ** Says Fortetropin showed increase in the rate of muscle
protein synthesis in older adults at a study conducted at
University of California, Berkeley and the University of
Arkansas for Medical Sciences
    ** CEO Joseph Mannello says the results from this study will
form the cornerstone of MYOS' 'Healthy Aging' business unit
    ** Co schedules conf call at 11:00 a.m. ET
    ** MYOS down 8.4% this year

 (Reporting by Medha Singh in Bengaluru)
 ((medha.singh@thomsonreuters.com))